Download Sample
Add to CartInterventional Cardiology And Peripheral Vascular Devices Market
By Product;
Coronary Stents, Percutaneous, Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Peripheral Vascular Stents, Angioplasty Catheters, Guidewires, Atherectomy Devices, Embolic Protection Devices, Vascular Closure Devices and OthersBy Procedure;
Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy, and Peripheral AtherectomyBy Indication;
Peripheral Arterial Disease And Coronary InterventionBy End User;
Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Specialty Clinics and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Interventional Cardiology and Peripheral Vascular Devices Market Overview
Interventional Cardiology and Peripheral Vascular Devices Market (USD Million)
Interventional Cardiology and Peripheral Vascular Devices Market was valued at USD 16,212.07 million in the year 2024. The size of this market is expected to increase to USD 23,117.91 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.2%.
Interventional Cardiology And Peripheral Vascular Devices Market
*Market size in USD million
CAGR 5.2 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 5.2 % |
| Market Size (2024) | USD 16,212.07 Million |
| Market Size (2031) | USD 23,117.91 Million |
| Market Concentration | Medium |
| Report Pages | 365 |
Major Players
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Johnson & Johnson
- Terumo Corporation
- B. Braun Melsungen AG
- Cardinal Health, Inc
- Cook Medical
- Edwards Lifesciences Corporation
- Penumbra, Inc
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Interventional Cardiology And Peripheral Vascular Devices Market
Fragmented - Highly competitive market without dominant players
The Interventional Cardiology and Peripheral Vascular Devices Market is witnessing robust expansion driven by the rising preference for minimally invasive procedures. Over 60% of patients undergoing vascular treatment opt for catheter-based interventions over traditional surgeries. The reduced recovery time and lower complication risks are significantly boosting the use of these advanced devices across healthcare systems.
Technological Advancements Enhancing Device Efficacy
Innovations in stent technologies, imaging systems, and drug-coated devices are contributing to improved procedural success rates. Around 45% of healthcare facilities report increased usage of next-generation imaging and navigation tools for real-time precision. This technological integration is enhancing clinical outcomes and facilitating complex interventions with greater safety.
Rising Prevalence of Cardiovascular Conditions
The growing incidence of coronary artery disease, peripheral artery disease, and related conditions is fueling demand. Nearly 70% of cardiovascular interventions now involve interventional devices due to the surge in high-risk patient populations. Factors such as sedentary lifestyles, diabetes, and hypertension are pushing the market forward.
Strategic Collaborations and Product Development
Companies are engaging in strategic partnerships and rapid product rollouts to address emerging clinical needs. Around 40% of firms in this space have introduced new devices that combine drug-elution technology with biodegradable platforms. Such collaborations are accelerating the availability of innovative treatments and strengthening the competitive landscape.
Interventional Cardiology and Peripheral Vascular Devices Market Recent Developments
-
In 2020, Edward Lifesciences Corporation (US) has received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) who are unable to undergo open-heart surgery
-
In 2020, Biotronk SE & Co. KG, Received CE approval for its Orsiro Mission Drug-eluting Stent.
Interventional Cardiology and Peripheral Vascular Devices Market Segment Analysis
In this report, the Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Product, Procedure, Indication, End User, and Geography.
Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Product
The Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Product into Coronary Stents, Percutaneous, Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Peripheral Vascular Stents, Angioplasty Catheters, Guidewires, Atherectomy Devices, Embolic Protection Devices, Vascular Closure Devices, and Others.
Coronary Stents
Coronary stents account for over 30% of the interventional cardiology market. Their widespread use in treating coronary artery diseases and the growing prevalence of cardiovascular disorders are key growth drivers.
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters
PTCA balloon catheters hold around 15% market share. They are essential in minimally invasive procedures for dilating narrowed arteries, contributing to improved patient outcomes.
Peripheral Vascular Stents
Peripheral vascular stents represent approximately 12% of the market. These devices are vital in managing peripheral artery disease, particularly in aging populations where arterial health is a concern.
Angioplasty Catheters
Angioplasty catheters account for nearly 10% of product usage. Their ability to restore blood flow in blocked vessels makes them a core component of interventional procedures.
Guidewires
Guidewires make up around 8% of the market. Their precision in navigating vascular pathways enhances the safety and effectiveness of catheter-based interventions.
Atherectomy Devices
Atherectomy devices contribute close to 7% share. Used to remove plaque from arteries, these devices are increasingly favored in complex vascular cases and challenging anatomy.
Embolic Protection Devices
Embolic protection devices have a 5% share. They reduce the risk of embolism during stent placement, especially in carotid artery procedures.
Vascular Closure Devices
These devices hold about 6% market share. They enable faster hemostasis post-procedure, improving patient comfort and reducing hospital stay duration.
Others
The "Others" category comprises miscellaneous devices with a combined 7% share, including support catheters, inflation devices, and accessory tools essential for procedural success.
Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Procedure
The Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Procedure into Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy, and Peripheral Atherectomy.
Iliac Intervention
Iliac interventions contribute to approximately 20% of peripheral vascular procedures. These are primarily conducted to restore blood flow in the iliac arteries, especially in patients with peripheral artery disease.
Femoropopliteal Interventions
Femoropopliteal procedures hold a share of nearly 30% in the market. This segment is growing due to increased demand for minimally invasive techniques in treating femoral and popliteal artery blockages, particularly among aging populations.
Tibial (Below-The-Knee) Interventions
Tibial interventions comprise around 15% of procedural volume. These are critical for patients with critical limb ischemia or diabetes, aiming to preserve limb function and prevent amputations.
Peripheral Angioplasty
Peripheral angioplasty makes up roughly 18% of procedures. It involves the use of balloon catheters to open narrowed arteries, offering rapid restoration of blood flow with minimal risks.
Arterial Thrombectomy
Arterial thrombectomy accounts for about 10%. It is used in cases of acute arterial occlusion to remove clots, especially in emergency settings, helping preserve limb viability.
Peripheral Atherectomy
Peripheral atherectomy has a market share of 7%. This procedure is effective for calcified plaques, enabling precise plaque removal and offering improved outcomes for patients unsuitable for stents.
Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Indication
The Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Indication into Peripheral Arterial Disease And Coronary Intervention.
Peripheral Arterial Disease
Peripheral Arterial Disease (PAD) accounts for approximately 40% of the total market. The rising prevalence of atherosclerosis and diabetes has increased the demand for minimally invasive interventions to restore blood flow, reduce amputation risks, and enhance mobility in affected patients.
Coronary Intervention
Coronary Intervention dominates the market with a share of nearly 60%. These procedures address coronary artery disease through the use of stents and balloon angioplasty, significantly lowering the incidence of heart attacks and improving overall cardiac outcomes.
Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by End User
The Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Specialty Clinics, and Others.
Hospitals
Hospitals account for over 60% of the market share due to their advanced infrastructure, presence of cardiovascular specialists, and capability to perform complex interventions. Their comprehensive services and critical care support solidify their dominance.
Ambulatory Surgical Centers
Ambulatory Surgical Centers (ASCs) are gaining popularity, holding nearly 15% of the market. Their cost-effective model, shorter recovery times, and suitability for day-care procedures make them increasingly preferred for elective interventions.
Cardiac Catheterization Laboratories
Cardiac Catheterization Labs contribute around 12% of the market. They provide specialized diagnostic services and interventional procedures, delivering precise treatment especially in high-volume urban healthcare facilities.
Specialty Clinics
Specialty Clinics represent 7–8% of the market, focusing on outpatient cardiac care, follow-up services, and reducing hospital readmissions. Their personalized care model supports continuity in cardiac treatment.
Others
The 'Others' segment, including academic and mobile health units, holds 5–6% of the market. These entities play a vital role in research and training, expanding cardiovascular awareness, and ensuring service accessibility in remote areas.
Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Geography
In this report, the Global Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
Global Interventional Cardiology and Peripheral Vascular Devices Market Share (%), by Geographical Region
North America
North America holds the largest share in the global market, accounting for around 38–40%. This is supported by a high prevalence of cardiovascular diseases, strong healthcare infrastructure, and increased adoption of advanced interventional devices.
Europe
Europe contributes approximately 28–30% of the global market. The region benefits from a growing geriatric population, robust healthcare reimbursement systems, and wider use of minimally invasive cardiac procedures.
Asia Pacific
Asia Pacific is the fastest-growing region, with a CAGR of over 8%. Key drivers include rising healthcare investments, growth in medical tourism, and increasing cases of lifestyle-induced cardiac conditions.
Middle East & Africa
Middle East and Africa make up about 6–7% of the global market. Growth is driven by better access to healthcare, increasing cardiovascular awareness, and expansion of private healthcare networks.
Latin America
Latin America contributes nearly 5–6% to the global market. This growth is supported by enhanced government initiatives, improved cardiac care facilities, and greater focus on preventive diagnostics in nations like Brazil and Mexico.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Interventional Cardiology and Peripheral Vascular Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers
- Technological advancements
- Increasing prevalence of cardiovascular diseases
- Growing aging population
-
Rising demand for minimally invasive procedures: The global interventional cardiology and peripheral vascular devices market is witnessing a robust growth trajectory, largely propelled by the rising demand for minimally invasive procedures. Minimally invasive techniques have gained significant traction in recent years due to their numerous benefits over traditional surgical methods. These procedures offer shorter recovery times, reduced hospital stays, and lower risk of complications, making them increasingly preferred by both patients and healthcare providers.
Advancements in technology have led to the development of innovative interventional cardiology and peripheral vascular devices, further driving market growth. These devices enable healthcare professionals to perform complex procedures with greater precision and efficacy. For instance, the introduction of drug-eluting stents has revolutionized the treatment of coronary artery disease by significantly reducing the risk of restenosis compared to bare-metal stents.
The growing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is fueling the demand for interventional cardiology and peripheral vascular devices. As the global population ages and lifestyles become increasingly sedentary, the incidence of these conditions is expected to rise, driving the need for effective treatment options. Consequently, manufacturers are investing in research and development activities to introduce innovative devices that address the evolving needs of patients and healthcare providers, further stimulating market growth.
Restraints
- High cost of devices
- Stringent regulatory requirements
- Limited reimbursement policies
-
Lack of skilled healthcare professionals: The global interventional cardiology and peripheral vascular devices market has experienced substantial growth over the years, driven by technological advancements and the rising prevalence of cardiovascular diseases worldwide. However, one significant challenge facing this market is the lack of skilled healthcare professionals proficient in utilizing these advanced devices.
Interventional cardiology procedures such as angioplasty and stent placements require specialized training and expertise. As these procedures become more complex with the introduction of newer devices and techniques, there is a growing demand for healthcare professionals who are adequately trained to perform them safely and effectively. However, the supply of such skilled professionals often lags behind, leading to longer wait times for procedures and potentially compromising patient care.
The shortage of skilled healthcare professionals in interventional cardiology and peripheral vascular devices extends beyond physicians to include nurses, technologists, and support staff. These individuals play crucial roles in assisting during procedures, managing equipment, and providing post-operative care. A shortage of trained personnel in these roles can hinder the efficient functioning of interventional cardiology units and limit patient access to timely interventions.
Opportunities
- Emerging markets expansion
- Development of innovative devices
- Integration of AI and IoT
-
Focus on preventive cardiology programs: The global interventional cardiology and peripheral vascular devices market is witnessing significant growth, driven by a heightened focus on preventive cardiology programs. As healthcare systems worldwide recognize the importance of proactive measures to combat cardiovascular diseases (CVDs), there's a growing emphasis on interventional cardiology devices aimed at both treatment and prevention. These devices play a crucial role in addressing a wide range of cardiovascular conditions, from coronary artery disease to peripheral artery disease, offering minimally invasive solutions that reduce patient recovery time and enhance overall outcomes.
Preventive cardiology programs are gaining traction as healthcare providers increasingly prioritize strategies aimed at averting CVDs before they escalate into serious health crises. By integrating interventional cardiology devices into these programs, healthcare professionals can identify and address risk factors early on, implementing interventions such as angioplasty, stenting, and atherectomy to restore blood flow and prevent further complications. This proactive approach not only improves patient outcomes but also reduces the burden on healthcare systems by curbing the incidence of costly cardiac procedures and hospitalizations.
Technological advancements in interventional cardiology and peripheral vascular devices are enhancing their effectiveness in preventive care. Innovations such as drug-eluting stents, bioresorbable scaffolds, and advanced imaging modalities enable more precise diagnosis and treatment planning, facilitating personalized interventions tailored to each patient's unique cardiovascular profile. As these technologies continue to evolve, supported by ongoing research and development efforts, the global market for interventional cardiology and peripheral vascular devices is poised for sustained growth, contributing to the advancement of preventive cardiology initiatives worldwide.
Competitive Landscape Analysis
Key players in Global Interventional Cardiology and Peripheral Vascular Devices Market include:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Johnson & Johnson
- Terumo Corporation
- B. Braun Melsungen AG
- Cardinal Health, Inc
- Cook Medical
- Edwards Lifesciences Corporation
- Penumbra, Inc
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Procedure
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Interventional Cardiology and Peripheral Vascular Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological advancements
- Increasing prevalence of cardiovascular diseases
- Growing aging population
- Rising demand for minimally invasive procedures
- Restraints
- High cost of devices
- Stringent regulatory requirements
- Limited reimbursement policies
- Lack of skilled healthcare professionals
- Opportunities
- Emerging markets expansion
- Development of innovative devices
- Integration of AI and IoT
- Focus on preventive cardiology programs
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Interventional Cardiology and Peripheral Vascular Devices Market, By Product, 2021 - 2031 (USD Million)
- Coronary Stents
- Percutaneous
- Transluminal Coronary Angioplasty (PTCA) Balloon Catheters
- Peripheral Vascular Stents
- Angioplasty Catheters
- Guidewires
- Atherectomy Devices
- Embolic Protection Devices
- Vascular Closure Devices
- Others
- Interventional Cardiology and Peripheral Vascular Devices Market, By Procedure, 2021 - 2031 (USD Million)
- Iliac Intervention
- Femoropopliteal Interventions
- Tibial (Below-The-Knee) Interventions
- Peripheral Angioplasty
- Arterial Thrombectomy
- Peripheral Atherectomy
- Interventional Cardiology and Peripheral Vascular Devices Market, By Indication, 2021 - 2031 (USD Million)
- Peripheral Arterial Disease
- Coronary Intervention
- Interventional Cardiology and Peripheral Vascular Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
- Specialty Clinics
- Others
- Interventional Cardiology and Peripheral Vascular Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
- Interventional Cardiology and Peripheral Vascular Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Johnson & Johnson
- Terumo Corporation
- B. Braun Melsungen AG
- Cardinal Health, Inc
- Cook Medical
- Edwards Lifesciences Corporation
- Penumbra, Inc
- Company Profiles
- Analyst Views
- Future Outlook of the Market